EGFR and glioblastoma: The JAK/STAT pathway is another important oncogenic pathway related to EGFR, which promotes GBM cell proliferation, angiogenesis, resistance to apoptosis, and immune escape through downstream targets, such as Bcl-xL, Bcl-2l1, Bcl-2, cyclin D1, and c-Myc.